Related Experiment Video
Updated: May 29, 2026
05:15
Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia
Published on: June 21, 2024
Brain cooling and eligible newborns: should we extend the indications?
1Neonatology-Neonatal Intensive Care Unit S. Croce and Carle Hospital, Cuneo, Italy. gancia.p@ospedale.cuneo.it
Summary
Therapeutic hypothermia is a standard treatment for hypoxic ischemic encephalopathy (HIE) in term infants, reducing mortality and disability. Further research is needed on its safety and efficacy in preterm infants and other neonatal conditions.
Area of Science:
- Neonatal neurology
- Pediatric critical care
- Therapeutic hypothermia
Background:
- Therapeutic hypothermia is standard care for term infants with hypoxic ischemic encephalopathy (HIE).
- Studies show reduced mortality and neurodevelopmental disability in term newborns with HIE.
- HIE in preterm infants differs pathologically and clinically from term infants.
Purpose of the Study:
- To review the current evidence and potential future applications of therapeutic hypothermia in neonatal brain injury.
- To highlight the need for safety and efficacy data in preterm infants and other neonatal conditions.
Main Methods:
- Systematic review and meta-analysis of human newborn studies.
- Review of animal experimental models.
- Discussion of ongoing and proposed clinical trials.
Main Results:
- Therapeutic hypothermia reduces mortality and disability in term infants with HIE.
- Favorable effects are more pronounced in less severe HIE cases.
- Limited data exists on the safety and efficacy of hypothermia in preterm infants.
Conclusions:
- Therapeutic hypothermia is beneficial for term infants with HIE.
- More research, including safety studies and randomized trials, is crucial for preterm infants, neonatal stroke, post-cardiac arrest, and necrotizing enterocolitis.
